UPDATE 1-UniQure's Huntington's therapy fails to significantly slow disease progression, shares plunge

0

(Updates shares, adds trial details and background in paragraphs 2, 3) Sept 29 (Reuters) – UniQure said its gene therapy for Huntington's disease fell short of statistical significance on the main

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)